Latest news with #Guillain-BarreSyndrome
Time of India
14-05-2025
- Health
- Time of India
Karnataka high court allows ailing professor's wife to access his bank accounts
Bengaluru: Karnataka high court has authorised the wife of a bedridden professor to operate his bank accounts to access funds to manage his medical and also household M Nagaprasanna gave the ruling, allowing a petition filed by Sandya, a Bengaluru resident and wife of Dr HV Anil sought the court's intervention after her husband was diagnosed with Guillain-Barre Syndrome , a rare neurological disorder, requiring continuous mechanical ventilation. Dr Kumar was hospitalised shortly before he retired on Nov 12, June 23, 2024, he is under intensive care and on ventilator support. Bangalore Medical College and Research Institute's neurology department confirmed his condition on Nov 29, providing documentation with a plea to access Dr Kumar's three bank accounts (two in State Bank of India, and one in Indian Overseas Bank), the banks did not act upon her requests, compelling her to seek judicial intervention. The banks submitted that Dr Kumar's accounts had been "inoperative" for some counsel H Venkatesh Dodderi said Dr Kumar had been in ICU for over nine months, unable to sign documents due to his comatose reviewing the evidence, Justice Nagaprasanna noted that medical certificates consistently indicated Dr Kumar's inability to write or move due to severe limb weakness. The judge referred to similar rulings by Kerala and Allahabad high courts where guardianship was granted in comparable court noted that Guillain-Barre Syndrome is a disorder that affects the peripheral nervous system, causing muscle weakness and paralysis. Given Dr Kumar's condition, the judge deemed it appropriate to authorise Sandya to operate her husband's court appointed Sandya as Dr Kumar's guardian and directed SBI and IOB to permit account operations for treatment expenses and family maintenance. The court granted her the liberty to seek further assistance, if needed, and instructed the banks to facilitate immediate account access without delays.
Yahoo
09-04-2025
- Health
- Yahoo
Guillain-Barre Syndrome Diagnostics Market Trends Analysis and Forecast Report 2025-2034: Advancements in Neurological Testing and Early Diagnosis Awareness Drive Growth
Guillain-Barre Syndrome Diagnostics Market Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Guillain-Barre Syndrome Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to Guillain-Barre Syndrome Diagnostics Market was valued at USD 148.3 million in 2024, and is projected to reach USD 196.7 million by 2034, rising at a CAGR of 2.9% The growth is driven by advancements in neurological testing methods and rising awareness of early diagnosis. The increasing prevalence of autoimmune disorders, improved accessibility to diagnostic procedures, and growing investments in healthcare infrastructure contribute to this upward trend. As medical technology evolves, healthcare providers are focusing on enhancing diagnostic accuracy to facilitate timely intervention, reducing the risk of severe complications associated with GBS. Healthcare facilities worldwide are prioritizing GBS screening, integrating state-of-the-art equipment to improve diagnostic precision. Research and development initiatives are also fostering innovation, with companies exploring new biomarker-based testing approaches that could revolutionize the diagnostic market is segmented based on test types, including lumbar puncture, nerve conduction studies, electromyography, and other diagnostic methods. In 2024, the lumbar puncture segment led the market, generating USD 66.3 million. As a gold-standard diagnostic procedure, lumbar puncture enables cerebrospinal fluid analysis, which helps confirm GBS by detecting elevated protein levels with normal white blood cell counts. This method is highly regarded for its reliability and accuracy, making it the preferred choice among healthcare professionals. With ongoing technological advancements, lumbar puncture techniques continue to improve, ensuring enhanced patient applications of Guillain-Barre syndrome diagnostics include hospitals and clinics, diagnostic laboratories, and other healthcare facilities. Hospitals and clinics dominated the market in 2024, accounting for 62.1% of the total share. These facilities remain the primary settings for GBS diagnosis due to the availability of specialized neurology units, experienced medical professionals, and cutting-edge diagnostic equipment. Neurology centers and general hospitals conduct the majority of GBS tests, including nerve conduction studies, electromyography, and lumbar punctures. The presence of well-equipped laboratories within hospitals ensures that patients receive prompt and accurate diagnoses, reinforcing the dominance of this the United States, the Guillain-Barre syndrome diagnostics market generated USD 48.8 million in 2023 and is expected to reach USD 65.7 million by 2034. The rising incidence of GBS has intensified efforts to enhance diagnostic capabilities, with healthcare providers emphasizing early detection and intervention. The country's aging population further contributes to market expansion, as older individuals face an increased risk of developing autoimmune disorders. As a result, demand for innovative diagnostic solutions is growing, prompting manufacturers to invest in research and development. Expanding healthcare policies and improved insurance coverage are also playing a role in accelerating market growth, making GBS diagnostics more accessible across the US healthcare landscape. Major Companies Featured in this Guillain-Barre Syndrome Diagnostics Market Report Alpine Biomed Avanos Bionen Medical Devices Cadwell Industries Cardinal Health Clarity Medical Deymed Diagnostic EMS Biomedical Medtronic Natus Medical Incorporated Neurosoft Nihon Kohden Rochester Electro-Medical Key Attributes: Report Attribute Details No. of Pages 122 Forecast Period 2024 - 2034 Estimated Market Value (USD) in 2024 $148.3 Million Forecasted Market Value (USD) by 2034 $196.7 Million Compound Annual Growth Rate 2.9% Regions Covered Global Key Topics Covered: Chapter 1 Methodology and ScopeChapter 2 Executive Summary2.1 Industry 360 synopsisChapter 3 Industry Insights3.1 Industry ecosystem analysis3.2 Industry impact forces3.2.1 Growth drivers3.2.1.1 Increasing incidence of Guillain-Barre syndrome3.2.1.2 Growing awareness for the rare disease3.2.1.3 Technological advancements in diagnostics3.2.1.4 Rise in aging population3.2.2 Industry pitfalls and challenges3.2.2.1 High diagnostic costs3.3 Growth potential analysis3.4 Regulatory landscape3.5 Technological landscape3.6 Future market trends3.7 Gap analysis3.8 Porter's analysis3.9 PESTEL analysisChapter 4 Competitive Landscape, 20244.1 Introduction4.2 Company market share analysis4.3 Company matrix analysis4.4 Competitive analysis of major market players4.5 Competitive positioning matrix4.6 Strategy dashboardChapter 5 Market Estimates and Forecast, by Test Type, 2021-2034 ($ Mn)5.1 Key trends5.2 Lumbar puncture5.3 Nerve conduction5.4 Electromyography5.5 Other test typesChapter 6 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)6.1 Key trends6.2 Hospitals and clinics6.3 Diagnostic laboratories6.4 Other end useChapter 7 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)7.1 Key trends7.2 North America7.2.1 U.S.7.2.2 Canada7.3 Europe7.3.1 Germany7.3.2 UK7.3.3 France7.3.4 Spain7.3.5 Italy7.3.6 Netherlands7.4 Asia-Pacific7.4.1 China7.4.2 India7.4.3 Japan7.4.4 Australia7.4.5 South Korea7.5 Latin America7.5.1 Brazil7.5.2 Mexico7.5.3 Argentina7.6 Middle East and Africa7.6.1 Saudi Arabia7.6.2 South Africa7.6.3 UAEChapter 8 Company ProfilesFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Guillain-Barre Syndrome Diagnostics Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
USA Today
21-02-2025
- Sport
- USA Today
Zack Martin's retirement after stellar 11-year career cements Cowboys' Ineptitude Era
It's the end of an era. Zack Martin has retired from football after an 11-year career, all spent with the Dallas Cowboys. Martin's resume is immaculate; missing more than two games in a season just twice in his career, he was named to the Pro Bowl and All-Pro teams each of the other nine campaigns. He entered the league a dominant force of nature as soon as he was drafted from Notre Dame and converted from tackle to guard. When Martin joined the Cowboys in 2014, he was the final piece of the puzzle. Dallas' front office had see enough. Franchise quarterback Tony Romo was being asked to do too much, and the club wasn't protecting him at levels that allowed the veteran quarterback to perform at his best. In Jason Garrett's first full season as head coach, the offensive line finally became a priority for the organization. Dallas drafted USC cyborg Tyron Smith that season, moving him from right tackle to left tackle the following year. After confirming they had their franchise left tackle, Dallas then drafted Wisconsin's Travis Frederick in 2013's first round, followed by Martin the next year. For several years, the Cowboys boasted one of the most impressive offensive lines in the league. All-Pros and Pro Bowls rained down as Dallas had a core position group that was supposed to lead to championships. But those aren't promised and good things don't last forever. Soonafter the second iteration of the Great Wall of Dallas hit their groove, Romo's body began to break down. Somehow Dallas lucked into a second-consecutive franchise QB in Dak Prescott, but that joy didn't last long either. A unique medical condition robbed Frederick of his prime years and eventually his career, and Smith began suffering a consistent stream of injuries year after year. Frederick missed all of 2018 with Guillain-Barre Syndrome, an auto-immune disease. Smith, who missed three whole games and parts of several others every season from 2016 through 2019, started experiencing major issues in 2020. With Frederick retired, Smith played just two games that season (only 30 over four years), the first campaign where Martin was the last man standing. Unfazed, Martin continued to play with sheer excellence, year after year, consistently protecting his quarterback and making running lanes for backs. Even when he wasn't his usual best, in 2023, he was still the best in the league, earning his seventh First-Team All-Pro and ninth overall. But Martin knew the end was nearing. He had publicly floated the possibility of retirement earlier that summer, holding out until the final two seasons of his contract were guaranteed. Dallas had released Smith that prior spring, leaving Martin as the elder statesman of the offensive line. Taking direction from a new OL coach in Mike Solari, the time Martin missed and the new system, along with age, allowed flaws in the armor to start to appear. In 2024, Martin wasn't the same and he struggled long before the myriad of injuries took their toll. After 10 games, he had enough and was placed on injured reserve. Now, facing free agency, he's decided his body has had enough, hanging up his cleats. And with his retirement, he adds his name to a ridiculously long list of star Cowboys who have now seen their career come to an end without Dallas ever hoisting the Lombardi trophy. Martin, Smith and Frederick. Romo. Prescott. Jason Witten. Dez Bryant. DeMarcus Ware. Flozell Adams. Miles Austin. DeMarco Murray. Ezekiel Elliott. Dexter Coakley. Dat Nguyen. Sean Lee. LaRoi Glover. Jay Ratliff. Terrell Owens. The talent that has flowed through the various headquarter buildings since the end of the Triplets era has been immense. And they've all left Dallas without winning a championship.
Khaleej Times
26-01-2025
- Health
- Khaleej Times
India probes mystery illness after 17 die: reports
Authorities in Jammu and Kashmir were investigating a mysterious disease that has claimed the lives of 17 people, local media reports said on Saturday. The deaths, including those of 13 children, have occurred in the remote village of Badhaal in Jammu's Rajouri area since early December. The village was declared a containment zone earlier this week with around 230 people quarantined, the Press Trust of India (PTI) news agency reported. All of the fatalities had damage to the brain and nervous system, said Amarjeet Singh Bhatia, who heads Rajouri's government medical college. "The winter vacations have also been cancelled to deal with the medical alert situation," PTI quoted Bhatia as saying. The victims were members of three related families. The federal government has launched an investigation with health minister Jitendra Singh saying an initial probe suggested the deaths were "not due to any infection, virus or bacteria but rather a toxin". "There is a long series of toxins being tested. I believe a solution will be found soon. Additionally, if there was any mischief or malicious activity, that is also being investigated," PTI quoted Singh as saying. In a separate medical incident, authorities in the western city of Pune recorded at least 73 cases of a rare nerve disorder. Those infected with Guillain-Barre Syndrome (GBS) include 26 women and 14 of the patients are on ventilator support, PTI quoted an official as saying. In GBS, a person's immune system attacks the peripheral nerves, according to the World Health Organisation. The syndrome can impact nerves that control muscle movement which may lead to muscle weakness, loss of sensation in the legs of arms and those infected can face trouble swallowing and breathing.
